Description
This invention relates to a novel panel of serum biomarkers for diagnosing and/or assessing the aggressiveness of IPF. Additionally, specific combinations of the biomarkers can be used to evaluate the progression of disease. Lastly, there are methods of identifying agents useful in the treatment of IPF which target the biomarkers. The panel includes but is not limited to MMP1 and MMP7.
IP Status
https://patents.google.com/patent/US8846341B2
